Iodine Market Report 2026

The iodine market size has grown strongly in recent years. It will grow from $2.94 billion in 2025 to $3.19 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to iodine deficiency disorders driving iodized salt adoption, established use of iodine in antiseptics, growth of x-ray contrast media applications, dependence on caliche ore and brine extraction, expansion of animal feed supplementation.

The iodine market size is expected to see strong growth in the next few years. It will grow to $4.37 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing diagnostic imaging procedures, rising focus on micronutrient fortification, growth in pharmaceutical manufacturing, development of sustainable iodine recovery methods, expanding use in advanced materials and electronics. Major trends in the forecast period include rising demand for iodine in medical imaging and diagnostics, increasing use of iodine in pharmaceutical and nutritional applications, growing adoption of iodine-based biocides and disinfectants, expansion of recycling and sustainable iodine sourcing, increasing consumption of iodine in polymer and electronics manufacturing.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the iodine market in the coming years. Chronic diseases are long-term health conditions that persist over an extended period, typically exceeding three months, and often progress gradually. The rising occurrence of chronic diseases, including thyroid disorders, cardiovascular diseases, and cancer, fuels the demand for iodine because of its essential role in medical imaging, pharmaceutical products, and dietary supplements designed to manage and prevent these conditions. Iodine is crucial in managing chronic diseases by supporting thyroid function, regulating metabolism, boosting immune response, and reducing inflammation, all of which contribute to better overall health and disease resilience. For example, in January 2023, the National Library of Medicine, a US-based medical library, projected that 142.66 million Americans aged 50 and above are expected to have at least one chronic illness by 2050. Consequently, the rising prevalence of chronic diseases is propelling the growth of the iodine market.

Major companies in the iodine market are focusing on integrating advanced nanotechnology, such as nano-iodine infusion, to enhance product efficacy and application versatility. A nano-iodine infusion involves the intravenous delivery of iodine particles engineered at the nanoscale, which improves iodine absorption and antimicrobial activity within a single formulation. For example, in September 2024, I2Pure, a US-based specialty iodine formulations company, developed its proprietary nano-iodine platform, a nanotechnology designed to provide shelf-stable, pH-neutral iodine solutions for antisepsis, wound irrigation, and oral rinse applications. This platform features high free-iodine concentrations (hundreds of times higher than conventional products), room-temperature storage, and sterility in a ready-to-use format. I2Pure’s nano-iodine platform enhances cost management, formulation automation, and decision-making in healthcare product development by enabling more effective dosing and faster market introduction of iodine-based therapies.

In September 2024, Availity, a U.S.-based operator of a healthcare data and administrative network, formed a partnership with Iodine Software. Through this collaboration, Availity seeks to integrate Iodine's machine learning into Availity Essentials Pro to optimize health systems' revenue cycle management by preventing revenue leakage and boosting operational efficiency. Iodine Software LLC is a U.S.-based software company.

Major companies operating in the iodine market are Sociedad Química y Minera de Chile S.A., MilliporeSigma, ACF Minera S.A., Nippoh Chemicals Co. Ltd., ISE Chemicals Corporation, Algorta Norte S.A., Godo Shigen Co. Ltd., Iofina plc, American Elements, Deepwater Chemicals Inc., Kanto Chemical Co. Inc., Eskay Iodine, Salvi Chemicals Industries Limited, Azer Yod LLC, Junsei Chemical Co. Ltd.

Europe was the largest region in the iodine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iodine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the iodine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the iodine market by increasing costs for imported elemental iodine, iodinated compounds, and contrast media intermediates, affecting pharmaceutical, nutrition, and electronics segments. Regions dependent on imported iodine sources, particularly asia pacific and europe, are most impacted. These tariffs may elevate production costs and constrain supply. However, they are also encouraging recycling initiatives, alternative sourcing strategies, and domestic production investments to enhance supply chain resilience.

The iodine market research report is one of a series of new reports that provides iodine market statistics, including iodine industry global market size, regional shares, competitors with a iodine market share, detailed iodine market segments, market trends and opportunities, and any further data you may need to thrive in the iodine industry. This iodine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Iodine is a chemical element with the symbol I and atomic number 53, and it belongs to the halogen group in the periodic table, along with fluorine, chlorine, bromine, and astatine. It finds use in a variety of applications, including as a disinfectant, in the synthesis of thyroid hormones, in medical imaging, and as an additive in iodized salt to prevent iodine deficiency.

The primary forms of iodine include inorganic salts and complexes, elemental and isotopes, and organic compounds. Inorganic salts are ionic compounds composed of inorganic cations and anions, such as sodium chloride (NaCl). Iodine can be sourced from underground brines, seaweeds, caliche ore, and recycling, serving a wide range of end users such as pharmaceuticals, biocides, iodophors, X-ray contrast media, catalysts in polymer processing, optical polarizing films, human nutrition, fluorochemicals, animal feed, and other applications.

The iodine market consists of sales of products including iodized salt, antiseptics, thyroid medications, and photographic chemicals. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.